MiNK Therapeutics, Inc.
INKT
$14.57
-$0.33-2.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -56.85% | 27.45% | 54.88% | 64.69% | 56.40% |
| Total Depreciation and Amortization | 8.20% | -5.58% | 0.56% | 17.01% | -13.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 225.89% | 31.43% | -36.19% | -226.80% | -29.42% |
| Change in Net Operating Assets | 1,566.46% | -4.80% | -101.69% | 29.91% | -105.84% |
| Cash from Operations | 31.50% | 47.25% | 43.09% | 28.85% | 44.82% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.99% | -91.30% | -- | 126.67% | 26,292.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.99% | -99.99% | -- | 126.67% | 7,770.15% |
| Foreign Exchange rate Adjustments | 182.63% | 87.84% | -646.51% | -54.24% | -211.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -144.41% | -154.78% | 42.24% | 29.31% | 181.89% |